Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Diagnos Inc. (V:ADK)

Business Focus: IT Services & Consulting (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for ADK within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 22, 2024 16:16 ET
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final...
Read full article
Mar 04, 2024 15:45 ET
DIAGNOS Announces Grant of Stock Options
Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces a grant of 250,000 stock options to one...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-0.35
--
--
Price to Sales - TTM
90.06
4.66
4.17
Price to Book - most recent quarter
--
2.16
2.48
Price to Cash Flow per share - TTM
--
11.67
10.22
Price to Free Cash Flow per share - TTM
--
18.47
22.49
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 20244,689-16,955
Feb 29, 202421,64414,220
Feb 15, 20247,424-5,384
See Short Report

Business Summary

Sector:  Technology Industry:  IT Services & Consulting

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company's subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

See business summary

 

Twitter

Search (past week) for $ADK.CA ADK.V

  • No tweets found